当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析

康华生物

(300841)

  

流通市值:70.52亿  总市值:77.68亿
流通股本:1.22亿   总股本:1.35亿

康华生物(300841)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.06亿元,每股收益3.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益345475.90万元,未分配利润239633.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产395076.69万元,负债49600.79万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,060,378,720.25741,084,779.28311,367,042.841,577,395,401.05
营业总成本577,201,604.21365,393,381.89134,855,630.79959,259,718.87
营业利润462,651,015.19351,413,795.79172,154,952.48576,612,161.66
利润总额462,436,864.13351,302,336.81172,144,276.88573,993,594.59
净利润405,902,226.46306,554,841.9149,466,993.99509,215,964.75
其他综合收益----
综合收益总额405,902,226.46306,554,841.9149,466,993.99509,215,964.75
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,360,528,064.572,420,567,909.092,644,447,623.682,656,897,485.87
非流动资产合计1,590,238,876.091,559,139,828.11,557,286,354.431,552,370,826.37
资产总计3,950,766,940.663,979,707,737.194,201,733,978.114,209,268,312.24
流动负债合计486,031,887.64529,262,593.27588,528,448.58681,724,871.18
非流动负债合计9,976,053.379,404,746.5512,119,405.5713,491,693.68
负债合计496,007,941.01538,667,339.82600,647,854.15695,216,564.86
归属于母公司股东权益合计3,454,758,999.653,441,040,397.373,601,086,123.963,514,051,747.38
股东权益合计3,454,758,999.653,441,040,397.373,601,086,123.963,514,051,747.38
负债和股东权益合计3,950,766,940.663,979,707,737.194,201,733,978.114,209,268,312.24
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,128,507,441.97744,131,555.23371,879,330.791,514,447,475.15
经营活动现金流出小计875,584,606.5568,340,535.87273,289,406.07940,464,141.34
经营活动产生的现金流量净额252,922,835.47175,791,019.3698,589,924.72573,983,333.81
投资活动现金流入小计102,026,956.46100,751,291.6650,000,00050,385,340.29
投资活动现金流出小计196,580,140.84156,238,542.98135,789,842.57213,774,690.48
投资活动产生的现金流量净额-94,553,184.38-55,487,251.32-85,789,842.57-163,389,350.19
筹资活动现金流入小计206,344,705.68166,344,705.6836,344,705.68221,754,880.79
筹资活动现金流出小计643,331,666.08557,724,37380,876,989.27228,872,244.12
筹资活动产生的现金流量净额-436,986,960.4-391,379,667.32-44,532,283.59-7,117,363.33
汇率变动对现金及现金等价物的影响1,592,860.871,784,397.5195,146.12-69,074.39
现金及现金等价物净增加额-277,024,448.44-269,291,501.78-31,537,055.32403,407,545.9
期末现金及现金等价物余额762,341,572.72770,074,519.381,007,828,965.841,039,366,021.16
最新报告期:2024-09-18
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
海通证券余文心5.606.106.782024-09-18
中信证券宋硕,陈竹5.135.696.222024-08-22
天风证券杨松5.036.016.782024-08-21
TOP↑